Minovia Therapeutics appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as board member
05. Januar 2023 08:00 ET
|
Minovia Therapeutics
TIRAT HACARMEL, Israel, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Minovia Therapeutics (Minovia), a clinical-stage company focused on developing novel Mitochondrial Augmentation Technology (MAT) to fight...
Minovia Therapeutics to Present at Biotech Showcase on Tuesday, January 10, 2023
03. Januar 2023 02:00 ET
|
Minovia Therapeutics
WOBURN, Mass. and HAIFA, Israel, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minovia Therapeutics, a clinical-stage global biotechnology company, today announced that the Company will be presenting at the...